How do you interpret a Thromboelastography (TEG) score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Interpret a Thromboelastography (TEG) Score

Thromboelastography (TEG) provides a comprehensive assessment of the entire coagulation process, from initial clot formation through fibrinolysis, allowing for real-time evaluation of hemostatic function. 1 Understanding TEG parameters is essential for accurate clinical decision-making in situations involving coagulopathy.

Key TEG Parameters and Their Interpretation

Initial Clot Formation Parameters

  • R time (Reaction time)

    • Measures time from test start to initial fibrin formation (normal: 5-10 minutes)
    • Reflects coagulation factor activity in the intrinsic pathway
    • Prolonged R: factor deficiency, anticoagulant effect
    • Shortened R: hypercoagulable state 1, 2
  • K time (Kinetics)

    • Time from beginning of clot formation until 20mm amplitude is reached (normal: 1-3 minutes)
    • Represents speed of clot formation
    • Prolonged K: hypofibrinogenemia, thrombocytopenia
    • Shortened K: hypercoagulable state 1, 3
  • Alpha angle (α)

    • Rate of clot formation (normal: 53-72°)
    • Reflects fibrinogen function and platelet interaction
    • Decreased angle: hypofibrinogenemia or platelet dysfunction
    • Increased angle: hypercoagulability 1, 3

Clot Strength Parameters

  • MA (Maximum Amplitude)
    • Maximum strength of the clot (normal: 50-70mm)
    • Represents platelet function and fibrinogen contribution
    • Decreased MA: thrombocytopenia, platelet dysfunction, hypofibrinogenemia
    • Increased MA: hypercoagulable state 1, 4
    • Studies show fibrinogen contributes 45% and platelets contribute 55% to overall clot strength 1

Clot Stability Parameters

  • LY30/LY60 (Lysis at 30/60 minutes)

    • Percentage of clot lysed at 30 or 60 minutes after MA
    • Reflects fibrinolytic activity
    • Increased values (>8%): hyperfibrinolysis
    • Decreased values: impaired fibrinolysis 1
  • CI (Coagulation Index)

    • Overall assessment of coagulation status
    • Combines R, K, MA, and α-angle
    • Negative values: hypocoagulable state
    • Positive values: hypercoagulable state 5, 3

Specialized TEG Assays

Modified TEG Tests

  • Heparinase TEG (hTEG)

    • Contains heparinase to neutralize heparin effect
    • Useful for assessing coagulation in heparinized patients 1
  • Functional Fibrinogen TEG (FLEV-TEG)

    • Uses GPIIb/IIIa platelet inhibitor to isolate fibrin contribution
    • Assesses relative contribution of platelets and fibrin to clot strength 1, 6
  • TEG Platelet Mapping (TEG-PM)

    • Uses ADP or arachidonic acid to assess platelet function
    • Evaluates effects of antiplatelet agents 1
  • Rapid TEG (rTEG)

    • Uses tissue factor plus kaolin to activate both intrinsic and extrinsic pathways
    • Provides faster results (within 5-15 minutes) compared to standard TEG
    • ACT (Activated Clotting Time) replaces R time 2

Clinical Applications and Interpretation Pearls

Hypercoagulable States

  • Pattern: Shortened R and K times, increased α-angle and MA
  • Common in pregnancy, malignancy, and post-operative states 1
  • MA-R ratio (MA divided by R time) can be useful for identifying hypercoagulable patients at risk of thrombosis 4

Hypocoagulable States

  • Pattern: Prolonged R and K times, decreased α-angle and MA
  • Seen in factor deficiencies, thrombocytopenia, and hemodilution 3

Fibrinolysis

  • Pattern: Normal initial parameters with declining amplitude after MA
  • Increased LY30/60 values indicate hyperfibrinolysis 1

Common Pitfalls in TEG Interpretation

  1. Sample handling issues

    • Delayed analysis can affect results
    • Proper collection technique is essential for accurate results
  2. Device variability

    • Results may vary between different TEG devices
    • Reference ranges are device-specific 1
  3. Operator dependency

    • Requires proper training and calibration
    • High coefficients of variance (7.1% to 39.9%) have been reported 1
  4. Hemolysis interference

    • Hemolysis can affect results, particularly in ECMO patients
    • Free hemoglobin can shorten coagulation times 7
  5. Limited sensitivity for platelet dysfunction

    • TEG may not provide a comprehensive assessment of platelet function
    • Should be supplemented with other platelet function tests when needed 6

TEG vs. Conventional Coagulation Tests

  • TEG results correlate with conventional tests but provide more comprehensive information
  • R time correlates with PT/INR and APTT
  • MA correlates with platelet count and fibrinogen levels
  • TEG provides faster results (5-15 minutes) compared to conventional tests (48 minutes) 2, 3

By understanding these parameters and their clinical significance, clinicians can effectively utilize TEG to guide transfusion therapy, monitor anticoagulation, and assess coagulation status in various clinical scenarios.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clot dynamics and mortality: The MA-R ratio.

The journal of trauma and acute care surgery, 2017

Research

Diagnostic Value of Thromboelastography (TEG) for the Diagnosis of Death in Infected Patients.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2021

Research

Value of thromboelastography in the assessment of platelet function.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2003

Guideline

Hemolysis and Its Impact on Coagulation Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.